Compare
Henry Schein vs Johnson & Johnson (HSIC vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Henry Schein (HSIC) returned +19.5% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +13.8% and +33.5%.
Johnson & Johnson is the larger company by market value, about 69.9 times the size of Henry Schein.
On trailing earnings, HSIC trades at 23.6 times and JNJ at 41.9 times.
Revenue grew +6.2% at HSIC and +7.8% at JNJ over the last year.
HSIC pays no dividend. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| HSIC | JNJ | |
|---|---|---|
| Price | $86.05 | $276.22 |
| 1-day | +0.87% | +1.43% |
| YTD | +13.85% | +33.47% |
| 1 year | +19.50% | +48.51% |
| 3 years | +34.31% | +85.77% |
| Market cap | $9.5B | $665.0B |
| P/E | 23.6 | 41.9 |
| P/S | 0.69 | 6.69 |
| P/B | 3.01 | 8.16 |
| Revenue growth | +6.20% | +7.80% |
| EPS growth | +15.10% | -36.40% |
| Gross margin % | 31.6 | 67.6 |
| Net margin % | 3.1 | 16.2 |
| ROE % | 13.3 | 19.7 |
| Debt / equity | 1.07 | 0.55 |
| FCF yield % | 5.9 | 3.1 |
| Dividend yield % | — | 1.91 |
| Beta | 0.62 | -0.09 |
| RSI (14) | 51.3 | 59.4 |
| Technical rating |